Breaking News Instant updates and real-time market news.

MYL

Mylan

$38.12

-0.35 (-0.91%)

12:51
10/03/16
10/03
12:51
10/03/16
12:51

Mylan slips lower

The shares hit a fresh 52-week at $37.41, with the stock having come off that low. Support is at $37.41 and then at $36.34. Resistance is at $39.35.

  • 07

    Oct

  • 28

    Mar

MYL Mylan
$38.12

-0.35 (-0.91%)

09/22/16
LEER
09/22/16
NO CHANGE
LEER
Outperform
No tangible outcomes likely to result from Mylan EpiPen hearing, says Leerink
Leerink analyst Jason Gerberry believes no tangible outcomes are likely to result from the House Committee Hearing on Mylan's EpiPen. Nonetheless, the analyst highlights that CEO Heather Bresch stated at the hearing that the company has invested in a new formulation of EpiPen, with a 24-month shelf life versus the current 12-month. Gerberry believes this is a relatively modest benefit and says he is skeptical the line extension will be able to preserve meaningful share if/when an AB-rated generic gets approved. The analyst reiterates an Outperform rating on the shares.
09/22/16
ARGS
09/22/16
NO CHANGE
ARGS
Mylan weakness creates good entry point, says Argus
After Mylan's stock fell 17% over the last month, Argus analyst Jacob Kilstein thinks that the stock has reached an attractive entry point, He says that the company's new generic EpiPen will cannibalize branded sales but should help it beat upcoming generic competitors. He thinks that the stock is undervalued and keeps a Buy rating on the stock.
09/23/16
BERN
09/23/16
NO CHANGE
BERN
Mylan generic Epipen to lower EPS by about 10%, says Bernstein
Bernstein analyst Aaron Gal estimates that Mylan's decision to introduce a generic version of its EpiPen will create a drag of about 10% on its EPS. After viewing the Congressional hearings on the device, Gal continues to believe that a competitor to EpiPen will hit the market before the end of 2018. He keeps a $60 price target and Outperform rating on Mylan.
09/30/16
LEER
09/30/16
NO CHANGE
Target $45
LEER
Outperform
Mylan price target cut to $45 on lower EpiPen estimates at Leerink
Leerink analyst Jason Gerberry lowered his EpiPen sales forecasts by 33-45% from 2017-2021 in light of recent company updates, including its plan to launch an authorized generic of the emergency treatment later this year. While Mylan "appears on the right side of the law" regarding the latest Medicaid rebate controversy, Gerberry believes investors should consider the risk of a future settlement related to the issue. He cut his price target on Mylan shares to $45 from $55, but keeps an Outperform rating on the stock as he sees cash flows being sufficient to justify the current price.

TODAY'S FREE FLY STORIES

HUBS

HubSpot

$72.15

-1.75 (-2.37%)

17:47
09/26/17
09/26
17:47
09/26/17
17:47
Earnings
HubSpot raises Q3 EPS view to (4c)-(2c) from (10c)-(8c), consensus (9c) »

Raises Q3 revenue view to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 04

    Oct

CSCO

Cisco

$33.76

0.04 (0.12%)

17:46
09/26/17
09/26
17:46
09/26/17
17:46
Periodicals
Cisco to cut around 310 headquarters jobs, Bloomberg reports »

Cisco is cutting about…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 28

    Sep

  • 29

    Sep

  • 05

    Oct

  • 06

    Oct

  • 18

    Oct

  • 19

    Oct

  • 22

    Oct

  • 15

    Nov

  • 07

    Dec

  • 11

    Dec

HUBS

HubSpot

$72.15

-1.75 (-2.37%)

17:45
09/26/17
09/26
17:45
09/26/17
17:45
Hot Stocks
Breaking Hot Stocks news story on HubSpot 

HubSpot raises Q3 outlook…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 04

    Oct

NKE

Nike

$53.70

0.47 (0.88%)

17:42
09/26/17
09/26
17:42
09/26/17
17:42
Earnings
Nike sees FY18 revenue growth in mid-single digit range, consensus $36.01B »

Sees FY18 gross margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 03

    Oct

  • 04

    Oct

  • 10

    Oct

NKE

Nike

17:41
09/26/17
09/26
17:41
09/26/17
17:41
Earnings
Nike sees Q2 revenue growth in low single digit range, consensus $8.48B »

Sees Q2 gross margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 03

    Oct

  • 04

    Oct

  • 10

    Oct

LLNW

Limelight Networks

$3.80

0.01 (0.26%)

17:36
09/26/17
09/26
17:36
09/26/17
17:36
Conference/Events
Limelight Networks management to meet with JMP Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 28

    Sep

  • 29

    Sep

  • 18

    Oct

  • 14

    Nov

  • 15

    Nov

CTAS

Cintas

$136.10

-0.77 (-0.56%)

, MU

Micron

$34.18

-0.69 (-1.98%)

17:35
09/26/17
09/26
17:35
09/26/17
17:35
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: Cintas…

CTAS

Cintas

$136.10

-0.77 (-0.56%)

MU

Micron

$34.18

-0.69 (-1.98%)

EDIT

Editas Medicine

$20.30

-0.83 (-3.93%)

TWTR

Twitter

$16.59

-0.39 (-2.30%)

NKE

Nike

$53.70

0.47 (0.88%)

KRNT

Kornit Digital

$17.15

-0.15 (-0.87%)

WLKP

Westlake Chemical Partners

$24.10

0.15 (0.63%)

ITCI

Intra-Cellular

$19.23

-0.57 (-2.88%)

ASND

Ascendis Pharma

$37.10

0.97 (2.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Sep

  • 26

    Sep

  • 26

    Sep

  • 03

    Oct

  • 04

    Oct

  • 10

    Oct

  • 27

    Sep

  • 27

    Sep

  • 28

    Sep

NKE

Nike

$53.70

0.47 (0.88%)

17:31
09/26/17
09/26
17:31
09/26/17
17:31
Hot Stocks
Nike: North America marketplace still undergoing 'significant' transformation »

Says seeing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 03

    Oct

  • 04

    Oct

  • 10

    Oct

BVXV

BiondVax

17:29
09/26/17
09/26
17:29
09/26/17
17:29
Hot Stocks
Breaking Hot Stocks news story on BiondVax »

Eastern Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKE

Nike

$53.70

0.47 (0.88%)

17:23
09/26/17
09/26
17:23
09/26/17
17:23
Hot Stocks
Nike 'bullish' on long-term opportunity in North America. »

Says sportswear category…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 03

    Oct

  • 04

    Oct

  • 10

    Oct

OIS

Oil States

$25.75

0.25 (0.98%)

, STL

Sterling Bancorp

$24.10

0.15 (0.63%)

17:22
09/26/17
09/26
17:22
09/26/17
17:22
Hot Stocks
Breaking Hot Stocks news story on Oil States, Sterling Bancorp »

Oil States to replace…

OIS

Oil States

$25.75

0.25 (0.98%)

STL

Sterling Bancorp

$24.10

0.15 (0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWTR

Twitter

$16.59

-0.39 (-2.30%)

17:21
09/26/17
09/26
17:21
09/26/17
17:21
Hot Stocks
Twitter to begin testing longer 280 character Tweets with small group »

Aliza Rosen, product…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KEM

Kemet

, AF

Astoria Financial

$21.09

0.08 (0.38%)

17:21
09/26/17
09/26
17:21
09/26/17
17:21
Hot Stocks
Breaking Hot Stocks news story on Kemet, Astoria Financial »

Kemet to replace Astoria…

KEM

Kemet

AF

Astoria Financial

$21.09

0.08 (0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

STL

Sterling Bancorp

$24.10

0.15 (0.63%)

, OIS

Oil States

$25.75

0.25 (0.98%)

17:20
09/26/17
09/26
17:20
09/26/17
17:20
Hot Stocks
Sterling Bancorp to repalce Oil States in S&P 400 at open on 10/2 »

Sterling Bancorp (STL) …

STL

Sterling Bancorp

$24.10

0.15 (0.63%)

OIS

Oil States

$25.75

0.25 (0.98%)

AF

Astoria Financial

$21.09

0.08 (0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWTR

Twitter

$16.59

-0.39 (-2.30%)

17:20
09/26/17
09/26
17:20
09/26/17
17:20
Hot Stocks
Twitter jumps after announcing testing for longer Tweets »

Shares of Twitter are up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIX

Six Flags

$58.02

0.25 (0.43%)

, PRXL

Parexel

$88.05

0.035 (0.04%)

17:18
09/26/17
09/26
17:18
09/26/17
17:18
Hot Stocks
Six Flags to replace Parexel in S&P 400 at open on 10/2 »

Pamplona Capital…

SIX

Six Flags

$58.02

0.25 (0.43%)

PRXL

Parexel

$88.05

0.035 (0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

NKE

Nike

17:16
09/26/17
09/26
17:16
09/26/17
17:16
Hot Stocks
Nike says Q1 online sales up 19% »

Says Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 03

    Oct

  • 04

    Oct

  • 10

    Oct

HOMB

Home Bancshares

$24.05

0.28 (1.18%)

, SGBK

Stonegate Bank

$51.62

0.59 (1.16%)

17:11
09/26/17
09/26
17:11
09/26/17
17:11
Hot Stocks
Home Bancshares announces completion of the acquisition of Stonegate Bank »

Home BancShares (HOMB)…

HOMB

Home Bancshares

$24.05

0.28 (1.18%)

SGBK

Stonegate Bank

$51.62

0.59 (1.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

TWTR

Twitter

$16.59

-0.39 (-2.30%)

17:11
09/26/17
09/26
17:11
09/26/17
17:11
Hot Stocks
Twitter to begin testing longer 280 character tweets with small group »

Aliza Rosen, product…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMH

American Homes 4 Rent

$22.03

0.04 (0.18%)

17:08
09/26/17
09/26
17:08
09/26/17
17:08
Hot Stocks
American Homes 4 Rent estimates to pay $10M in damage from recent hurricanes »

American Homes 4 Rent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMUS

T-Mobile

$63.03

0.14 (0.22%)

17:05
09/26/17
09/26
17:05
09/26/17
17:05
Hot Stocks
T-Mobile to acquire remaining interest of iWireless from Aureon »

T-Mobile US announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

ZSAN

Zosano Pharma

$0.79

-0.0498 (-5.93%)

17:04
09/26/17
09/26
17:04
09/26/17
17:04
Hot Stocks
Zosano Pharma provides patent application update »

Zosano Pharma received…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ELUXY

Electrolux AB

$69.63

-0.2675 (-0.38%)

17:02
09/26/17
09/26
17:02
09/26/17
17:02
Downgrade
Electrolux AB rating change  »

Electrolux AB downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOC

Northrop Grumman

$284.74

3.37 (1.20%)

17:01
09/26/17
09/26
17:01
09/26/17
17:01
Hot Stocks
Northrop Grumman COO Flach to retire, Warden named next COO »

Northrop Grumman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WBB

Westbury Bancorp

$20.05

-0.3508 (-1.72%)

17:00
09/26/17
09/26
17:00
09/26/17
17:00
Hot Stocks
Breaking Hot Stocks news story on Westbury Bancorp  »

Westbury Bancorp trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.